
Track Record
Team Launches
Our team has executed end-to-end launches across Rx, devices, diagnostics, digital health, and pharmacy in Canada.
-
Pharmaceuticals
- Eusa Pharma launch into Canada for Oncology/Rare Disease full setup
-
Jazz Pharma, Canadian Entry, Launch and train new staff for Oncology
-
Recordati Pharma Canadian Entry Launch and commercial build for Rare Diseas
-
Takeda Launch Oncology Canadian Launch
-
15 additional Rx launches spanning Oncology, Rare Disease (Orphan), Endocrine (e.g., Thyroid), plus an Adrenaline relaunch.
-
Multiple molecule introductions from Pfizer, Elvium Pharma and Boehringer Ingelheim
-
Diagnostics, Devices & Digital
-
Launched Omega Laboratories full diagnostic suite into Canada and full expansion
-
POCT diagnostics, medical devices, skin-care lines, and AI-enabled solutions.
-
-
Pharmacy & Generics
-
Community/specialty pharmacy channel activation and generics commercialization
-
Ophthalmology & Surgical
-
-
Experience in surgical/wound-closure supporting ophthalmic use cases.
-
AI SaMD, Digital Health Launch
Cases
Case Study 1
Launching a Rare Disease Company in Canada
Challenge:
A global pharma leader needed to launch a dormant rare disease treatment in Canada, which lacked any local medical or commercial infrastructure.
Our Approach:
We built the entire Canadian operation from the ground up, establishing the medical affairs and patient support infrastructure, creating a market-access strategy, and executing a tailored commercial launch.
Result:
Canada became the company's top-performing global affiliate, leading to full local independence and contributing to a major strategic acquisition. This case highlights our ability to execute full-scale, go-to-market transformations in highly specialized therapeutic areas.
Case Study 2
Scaling a Digital Health Platform for Acquisition
Challenge:
A continuing health education (CHE) platform struggled with physician skepticism and limited adoption, hindering its growth and exit potential.
Our Approach:
We optimized the platform, curated high-value content from Key Opinion Leaders (KOLs), and executed targeted growth campaigns to build credibility and drive user adoption across hospitals and associations.
Result:
The platform achieved rapid user adoption and was successfully acquired by a major healthcare education provider, demonstrating its lasting value. This case shows our expertise in scaling digital health ventures for successful exits.
Case Study 3
Disrupting a 59-Year Diagnostic Laboratory Monopoly
From market challenger to national presence in 18 months
The Challenge
A U.S.-based diagnostics lab entered the Canadian market long dominated by a single player. Strategic Growth AI delivered a comprehensive market entry strategy that transformed industry skepticism into widespread adoption, establishing the lab as a credible, trusted alternative.
Roadblocks We Overcame:
-
Market Resistance: Clients were deeply tied to the incumbent provider
-
Logistics Complexity: Vast geography + limited couriers raised delivery costs
-
Regulatory Barriers: Provincial + federal compliance requirements
-
Operational Scaling: Fast onboarding without compromising quality
-
Credibility Gap: Breaking 59 years of institutional loyalty required flawless execution
Results Achieved:
-
1,700+ client sites secured across Canada
-
Significant revenue growth via strategic partnerships
-
Market credibility as the first serious challenger in 6 decades
-
Operational scalability for long-term growth and excellence
-
Bottom Line: Our client became Canada's fastest-growing diagnostics company, proving that focused execution beats legacy dominance.



